{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:40Z","timestamp":1794541660710,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2831,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The impact of ethnicity on the natural history of autoimmune hepatitis (AIH) has not been well characterized. The aim of this study was to assess the natural history of AIH in blacks in comparison with others (nonblacks). This was a 10-year (June 1996 to June 2006) retrospective analysis of patients with AIH from a single tertiary care center. The diagnosis of AIH was defined by the criteria established by the International Autoimmune Hepatitis Club. A poor outcome was defined as liver failure at presentation, failure to achieve remission, need for liver transplantation, and\/or death. One hundred one patients with AIH were eligible for the study. Black patients were more likely to have cirrhosis (56.7% versus 37.5%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.061), have liver failure at the initial presentation (37.8% versus 9.3%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.001), and be referred for liver transplantation (51.3% versus 23.4%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.004). The overall mortality was also significantly higher in black patients (24.3% versus 6.2%,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.009). Compared with nonblacks, blacks had more advanced hepatic fibrosis (3.6 \u00b1 2.7 versus 2.1 \u00b1 2.4,<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.013). A Kaplan-Meier analysis showed that the probability of developing a poor outcome was significantly higher in blacks (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.003). Independent predictors of poor outcome were black ethnicity, the presence of cirrhosis, and the fibrosis stage at presentation. Black males were the group most likely to have a poor outcome (85.7%).<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>Blacks, especially black men with AIH, have more aggressive disease at the initial presentation, are less likely to respond to conventional immunosuppression, and have a worse outcome than nonblacks. (Hepatology 2007.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21884","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T23:46:36Z","timestamp":1187394396000},"page":"1828-1835","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":118,"title":["The impact of ethnicity on the natural history of autoimmune hepatitis"],"prefix":"10.1097","volume":"46","author":[{"given":"Sumita","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Torbenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20241201","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"R2-21-20241201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","article-title":"Drug therapy in management of type 1 autoimmune hepatitis.","volume":"57","author":"Czaja","year":"1999","journal-title":"Drugs"},{"key":"R3-21-20241201","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"R4-21-20241201","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R5-21-20241201","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jhep.2005.06.006","article-title":"Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.","volume":"43","author":"Miyake","year":"2005","journal-title":"J Hepatol"},{"key":"R6-21-20241201","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R7-21-20241201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"R8-21-20241201","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2036.2006.03113.x","article-title":"Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-21-20241201","first-page":"116","article-title":"Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis.","volume":"23","author":"Czaja","year":"2003","journal-title":"Liver"},{"key":"R10-21-20241201","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8DR3 are independent risk factors.","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"R11-21-20241201","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLAencoded susceptibility to type 1 autoimmune hepatitis.","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"R12-21-20241201","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"R13-21-20241201","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840150208","article-title":"Prognostic features and role of liver transplantation in severe corticosteroidtreated autoimmune chronic active hepatitis.","volume":"15","author":"SanchezUrdazpal","year":"1992","journal-title":"Hepatology"},{"key":"R14-21-20241201","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis.","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R15-21-20241201","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.50.5.713","article-title":"Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin.","volume":"50","author":"Zolfino","year":"2002","journal-title":"Gut"},{"key":"R16-21-20241201","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R17-21-20241201","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R18-21-20241201","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liverkidney microsome type 1 in adults with chronic active hepatitis.","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"R19-21-20241201","first-page":"2470","article-title":"In vitro response to immunosuppressive agents in blacks.","volume":"25","author":"Ward","year":"1993","journal-title":"Transplant Proc"},{"key":"R20-21-20241201","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-199312000-00020","article-title":"Ethnic variations in patient and graft survival after liver transplantation. Identification of a new risk factor for chronic allograft rejection.","volume":"56","author":"Devlin","year":"1993","journal-title":"Transplantation"},{"key":"R21-21-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"JF, for the FK506 Kidney Transplant Study Group. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine.","volume":"65","year":"1998","journal-title":"Transplantation"},{"key":"R22-21-20241201","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0041-1345(98)00275-9","article-title":"Demographic considerations in tacrolimus pharmacokinetics.","volume":"30","author":"Fitzsimmons","year":"1998","journal-title":"Transplant Proc"},{"key":"R23-21-20241201","first-page":"379","article-title":"The effect of race and ethnicity on kidney allograft outcome.","volume":"9","author":"Katznelson","year":"1995","journal-title":"Clin Transpl"},{"key":"R24-21-20241201","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1994.4","article-title":"Thiopurine methyltransferase activity in American white subjects and black subjects.","volume":"55","author":"McLeod","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"R25-21-20241201","first-page":"359","article-title":"Fast and slow methylators: do racial differences influence risk of allograft rejection?","volume":"86","author":"Chocair","year":"1993","journal-title":"Q J Med"},{"key":"R26-21-20241201","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy.","volume":"96","author":"Lim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R27-21-20241201","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroidtreated hepatitis B surface antigennegative chronic active hepatitis.","volume":"87","author":"Davis","year":"1984","journal-title":"Gastroenterology"},{"key":"R28-21-20241201","first-page":"9","article-title":"The effect of race on incidence and clinical course in systemic lupus erythematosus: the Hopkins lupus cohort.","volume":"53","author":"Petri","year":"1998","journal-title":"J Am Med Womens Assoc"},{"key":"R29-21-20241201","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/diacare.19.12.1344","article-title":"A two fold excess mortality among black compared with white IDDM patients in Allegheny county, Pennsylvania. Pittsburgh DERI Mortality Study Group.","volume":"19","author":"Tull","year":"1996","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"R30-21-20241201","first-page":"981","article-title":"","volume":"82","year":"2006","journal-title":"Transplantation"},{"key":"R31-21-20241201","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1478-3231.2005.01088.x","article-title":"An unusual form of autoimmune hepatitis in young Somalian men.","volume":"25","author":"DSouza","year":"2005","journal-title":"Liver Int"},{"key":"R32-21-20241201","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.20932","article-title":"In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow up associated with a poorer outcome?","volume":"42","author":"Verma","year":"2005","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21884","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200712000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:13:08Z","timestamp":1733058788000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200712000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21884","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}